A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer
A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer
Recruiting · NCT06631989 · Registry updated 2025-08-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer | EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer | Recruiting | Phase 1 / Phase 2 | 2025-08-29 | NCT06631989 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Wayshine Biopharm, Inc. | 3 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | China | 2 |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |
| He'nan Cancer Hospital | Zhengzhou | China | 1 |
| Shandong Cancer Hospital | Jinan | China | 86 |
| Shanghai Chest Hospital | Shanghai | China | 83 |
| Shanghai East Hospital | Shanghai | China | 17 |
| Shanghai Pulmonary Hospital | Shanghai | China | 72 |
| Sichuan Provincial Cancer Hospital | Chengdu | China | 2 |
| Taizhou Hospital of Zhejiang Province | Taizhou | China | 19 |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou | China | 3 |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou | China | 5 |
| Tianjin Medical University Cancer Institute and Hospital | Tianjin | China | 4 |